Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
1 August 2014
|
| In: |
International journal of cardiology
Year: 2014, Jahrgang: 176, Heft: 3, Pages: 1113-1115 |
| ISSN: | 1874-1754 |
| DOI: | 10.1016/j.ijcard.2014.07.106 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ijcard.2014.07.106 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0167527314013163 
|
| Verfasserangaben: | Arnt V. Kristen, Moritz Biener, Ute Hegenbart, Stefan Hardt, Philipp A. Schnabel, Christoph Röcken, Stefan O. Schonland, Hugo A. Katus, Evangelos Giannitsis |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1703737334 | ||
| 003 | DE-627 | ||
| 005 | 20220818142253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200706s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijcard.2014.07.106 |2 doi | |
| 035 | |a (DE-627)1703737334 | ||
| 035 | |a (DE-599)KXP1703737334 | ||
| 035 | |a (OCoLC)1341344557 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kristen, Arnt |d 1974- |e VerfasserIn |0 (DE-588)123480965 |0 (DE-627)706314530 |0 (DE-576)293726876 |4 aut | |
| 245 | 1 | 0 | |a Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis |c Arnt V. Kristen, Moritz Biener, Ute Hegenbart, Stefan Hardt, Philipp A. Schnabel, Christoph Röcken, Stefan O. Schonland, Hugo A. Katus, Evangelos Giannitsis |
| 264 | 1 | |c 1 August 2014 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.07.2020 | ||
| 650 | 4 | |a Atrial natriuretic peptide | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Light-chain amyloidosis | |
| 650 | 4 | |a N-terminal brain-type natriuretic peptide | |
| 650 | 4 | |a Survival | |
| 650 | 4 | |a Troponin T | |
| 700 | 1 | |a Biener, Moritz |d 1983- |e VerfasserIn |0 (DE-588)101853119X |0 (DE-627)682858374 |0 (DE-576)355963876 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Hardt, Stefan |e VerfasserIn |0 (DE-588)1028380585 |0 (DE-627)730637611 |0 (DE-576)375919309 |4 aut | |
| 700 | 1 | |a Schnabel, Philipp Albert |d 1953-2021 |e VerfasserIn |0 (DE-588)102254960X |0 (DE-627)717000087 |0 (DE-576)16982750X |4 aut | |
| 700 | 1 | |a Röcken, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Giannitsis, Evangelos |e VerfasserIn |0 (DE-588)113336241 |0 (DE-627)577184091 |0 (DE-576)289759579 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cardiology |d Amsterdam [u.a.] : Elsevier Science, 1981 |g 176(2014), 3, Seite 1113-1115 |h Online-Ressource |w (DE-627)306659581 |w (DE-600)1500478-8 |w (DE-576)081986270 |x 1874-1754 |7 nnas |a Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis |
| 773 | 1 | 8 | |g volume:176 |g year:2014 |g number:3 |g pages:1113-1115 |g extent:3 |a Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijcard.2014.07.106 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0167527314013163 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200706 | ||
| 993 | |a Editorial | ||
| 994 | |a 2014 | ||
| 998 | |g 113336241 |a Giannitsis, Evangelos |m 113336241:Giannitsis, Evangelos |d 910000 |d 910100 |e 910000PG113336241 |e 910100PG113336241 |k 0/910000/ |k 1/910000/910100/ |p 9 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |e 910000PS122405226 |e 910100PS122405226 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 102254960X |a Schnabel, Philipp Albert |m 102254960X:Schnabel, Philipp Albert |d 910000 |d 912000 |e 910000PS102254960X |e 912000PS102254960X |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1028380585 |a Hardt, Stefan |m 1028380585:Hardt, Stefan |d 50000 |e 50000PH1028380585 |k 0/50000/ |p 4 | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |e 910000PH1028373708 |e 910100PH1028373708 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 101853119X |a Biener, Moritz |m 101853119X:Biener, Moritz |d 910000 |d 910100 |e 910000PB101853119X |e 910100PB101853119X |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 123480965 |a Kristen, Arnt |m 123480965:Kristen, Arnt |d 910000 |d 910100 |e 910000PK123480965 |e 910100PK123480965 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1703737334 |e 3695779373 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1703737334","person":[{"role":"aut","family":"Kristen","given":"Arnt","display":"Kristen, Arnt"},{"role":"aut","family":"Biener","display":"Biener, Moritz","given":"Moritz"},{"display":"Hegenbart, Ute","given":"Ute","role":"aut","family":"Hegenbart"},{"display":"Hardt, Stefan","given":"Stefan","family":"Hardt","role":"aut"},{"family":"Schnabel","role":"aut","given":"Philipp Albert","display":"Schnabel, Philipp Albert"},{"family":"Röcken","role":"aut","given":"Christoph","display":"Röcken, Christoph"},{"role":"aut","family":"Schönland","given":"Stefan","display":"Schönland, Stefan"},{"given":"Hugo","display":"Katus, Hugo","family":"Katus","role":"aut"},{"family":"Giannitsis","role":"aut","given":"Evangelos","display":"Giannitsis, Evangelos"}],"note":["Gesehen am 06.07.2020"],"name":{"displayForm":["Arnt V. Kristen, Moritz Biener, Ute Hegenbart, Stefan Hardt, Philipp A. Schnabel, Christoph Röcken, Stefan O. Schonland, Hugo A. Katus, Evangelos Giannitsis"]},"language":["eng"],"relHost":[{"recId":"306659581","title":[{"title":"International journal of cardiology","title_sort":"International journal of cardiology"}],"id":{"eki":["306659581"],"issn":["1874-1754"],"zdb":["1500478-8"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1981-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1981"}],"language":["eng"],"part":{"issue":"3","extent":"3","pages":"1113-1115","text":"176(2014), 3, Seite 1113-1115","year":"2014","volume":"176"},"note":["Gesehen am 13.02.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1981 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosisInternational journal of cardiology"}],"origin":[{"dateIssuedDisp":"1 August 2014","dateIssuedKey":"2014"}],"title":[{"title_sort":"Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis","title":"Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"3 S."}],"id":{"eki":["1703737334"],"doi":["10.1016/j.ijcard.2014.07.106"]}} | ||
| SRT | |a KRISTENARNEVALUATION1201 | ||